Informatie over Shire International Licensing B.V. in Hoofddorp - Noord-Holland

Aalsmeerderbrug/ Oude Meer/ Rozenburg / Schiphol Rijk (8)
Abbenes / Buitenkaag (2)
Badhoevedorp (6)
Beinsdorp (1)
Burgerveen / Leimuiderbrug / Weteringbrug (2)
Cruquius (3)
Hoofddorp (50)
Lijnden / Boesingheliede (5)
Lisserbroek (2)
Nieuw-Vennep (10)
Rijsenhout (4)
Schiphol (10)
Vijfhuizen (2)
Zwaanshoek (1)
Zwanenburg (8)

U vindt veel meer informatie per bedrijf en veel meer bedrijven. Ook kunt u filters toepassen en exporteren naar Excel.

Shire International Licensing B.V.

Hoofddorp - Noord-Holland

Naam

Shire International Licensing B.V.

Website

Sector

Lease van niet-financiële immateriële activa

Werkenden

5-9 wn.

Adres

Adres verborgen. Dit bedrijf wil geen ongevraagde postreclame of verkoop aan de deur.

Postcode

2132HA

Plaatsnaam

Hoofddorp

-2025 12 1995 2025 2026 24 3 30 a about abov accept accessibility additional address administration advanc against aged agency agree all ambition an analyz and angioedema announc approved are areas as aspir assist attack balanced better brighter bringing busines by campaign can cancer carer centered ceo christoph chronic clicking colleagues commitment committed company complex condition constantly contact cookie cookies copyright cor corporat country creat cur curiosity d dat deliver derived development devic discover diseases disorder diver driving effort ema embrac enhanc european everyday everywher evolv exist february financial find focus for forecast forward from fueled full futur fy2024 gastrointestinal global globally growth hae has hcps health hematology hereditary highlight highly homepag how ibd immunology improv infectious inflammation inflammatory information inherent innovation innovativ inspiration into investor january join julie jun kim lanadelumab learn lif life-limit life-transform limit limited lives local location lysosomal march margin market medical medicines metabolic milestones mor mov navigation ned neurological neuroscienc new newsletter notic on oncology operat option our out outlok patient patient-centered peopl pharmaceutical phas planet plasma plasma-derived pleas policy polycythemia portfolio positiv privacy profit protagonist provides quarter r raises rar re recent recurrent reject remain reserved resilient result revenue right rusfertid s scienc selector setting sign sit so specific statement stay storag storing strategy strong study subcutaneous succed sustainabl takeda takhzyro technology term the therapies third third-quarter this through to toplin transform translat treatment understand unmet up us usag use vaccin vaccines vera verify view we weber websit whil who will with work working world worldwid year you your

Vind meer informatie over Shire International Licensing B.V. in de interactieve versie